<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01084356</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-10-EES-0649-CTIL</org_study_id>
    <nct_id>NCT01084356</nct_id>
  </id_info>
  <brief_title>Evaluation of a New CZT System</brief_title>
  <official_title>Evaluation of a New CZT System for Imaging in Routine Nuclear Medicine Examination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to check if the new CZT system has an advantage in detection of
      small osseous processes, thyroid adenomas, parathyroid adenomas and detection of sentinel
      node, in comparison with the techniques in use.

      Participants: 100 subjects male and female that come to the institute of nuclear medicine for
      routine screening examinations.

      The CZT screening takes 10 minutes and does not require any extra intervention to the routine
      screening.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <primary_completion_date type="Anticipated">March 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Parathyroid Adenoma</condition>
  <condition>Thyroid Adenoma</condition>
  <arm_group>
    <arm_group_label>hand</arm_group_label>
    <description>patients admitted for Tc MDP for evaluation of carpal/metacarpal and finger bone lesions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>thyroid</arm_group_label>
    <description>patients admitted for Tc thyroid scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>parathyroid</arm_group_label>
    <description>patients investigated for parathyroid adenoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sentinel node</arm_group_label>
    <description>patients who are due to sentinel node biopsy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        consequtive patiants admitted for the above scans and consented to be further investigated
        by the CZT system
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age over 18

        Exclusion Criteria:

          -  pregnancy

          -  patients unable to understand and sign an informed consent

          -  age under 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Einat Even Sapir, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv Sourasky Medical Center, Tel Aviv, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Einat Even Sapir, PhD,MD</last_name>
    <phone>972-3-6974444</phone>
    <phone_ext>3536</phone_ext>
    <email>evensap@tasmc.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ayelet Kurzband, BA</last_name>
    <phone>972-3-6974444</phone>
    <phone_ext>3536</phone_ext>
    <email>ayeletk@tasmc.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Einat Even Sapir, PhD, MD</last_name>
      <phone>972-3-6974444</phone>
      <phone_ext>3536</phone_ext>
      <email>evensap@tasmc.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Ayelet Kurzband, BA</last_name>
      <phone>972-3-6974444</phone>
      <phone_ext>3536</phone_ext>
      <email>ayeletk@tasmc.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Hedva Lerman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Einat Even-Sapir, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, Hutton B, Sharir T, Haim SB, Haim SB. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med. 2009 Apr;50(4):635-43. doi: 10.2967/jnumed.108.060020.</citation>
    <PMID>19339672</PMID>
  </reference>
  <reference>
    <citation>Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol. 2008 Dec;191(6):1805-15. doi: 10.2214/AJR.07.3693.</citation>
    <PMID>19020253</PMID>
  </reference>
  <reference>
    <citation>Mueller B, O'Connor MK, Blevis I, Rhodes DJ, Smith R, Collins DA, Phillips SW. Evaluation of a small cadmium zinc telluride detector for scintimammography. J Nucl Med. 2003 Apr;44(4):602-9.</citation>
    <PMID>12679406</PMID>
  </reference>
  <reference>
    <citation>Ketchum LE. New equipment in nuclear medicine, part 1: solid-state detectors. J Nucl Med. 1998 Nov;39(11):15N, 35N-36N.</citation>
    <PMID>9829562</PMID>
  </reference>
  <reference>
    <citation>Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc. 2005 Jan;80(1):24-30.</citation>
    <PMID>15667025</PMID>
  </reference>
  <reference>
    <citation>O'Connor MK, Phillips SW, Hruska CB, Rhodes DJ, Collins DA. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J. 2007 Jan-Feb;13(1):3-11.</citation>
    <PMID>17214787</PMID>
  </reference>
  <reference>
    <citation>Tsuchimochi M, Hayama K, Oda T, Togashi M, Sakahara H. Evaluation of the efficacy of a small CdTe gamma-camera for sentinel lymph node biopsy. J Nucl Med. 2008 Jun;49(6):956-62. doi: 10.2967/jnumed.108.050740. Epub 2008 May 15.</citation>
    <PMID>18483107</PMID>
  </reference>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2010</study_first_submitted>
  <study_first_submitted_qc>March 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2010</study_first_posted>
  <last_update_submitted>March 9, 2010</last_update_submitted>
  <last_update_submitted_qc>March 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Einat Even-Sapir MD, PhD. Head, Dept of Nuclear Medicine</name_title>
    <organization>Tel Aviv SoUrasky medical center</organization>
  </responsible_party>
  <keyword>CZT</keyword>
  <keyword>sentinel node</keyword>
  <keyword>osseous processes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Parathyroid Neoplasms</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

